Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2013 1
2015 1
2016 3
2017 2
2018 2
2019 3
2020 2
2021 4
2022 3
2023 10
2024 7
2025 10
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
STYX: a versatile pseudophosphatase.
Reiterer V, Pawłowski K, Farhan H. Reiterer V, et al. Biochem Soc Trans. 2017 Apr 15;45(2):449-456. doi: 10.1042/BST20160279. Biochem Soc Trans. 2017. PMID: 28408485 Review.
Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration.
Sumra V, Hadian M, Dilliott AA, Farhan SMK, Frank AR, Lang AE, Roberts AC, Troyer A, Arnott SR, Marras C, Tang-Wai DF, Finger E, Rogaeva E, Orange JB, Ramirez J, Zinman L, Binns M, Borrie M, Freedman M, Ozzoude M, Bartha R, Swartz RH, Munoz D, Masellis M, Black SE, Dixon RA, Dowlatshahi D, Grimes D, Hassan A, Hegele RA, Kumar S, Pasternak S, Pollock B, Rajji T, Sahlas D, Saposnik G, Tartaglia MC; ONDRI Investigators. Sumra V, et al. J Neurol. 2025 Jun 25;272(7):478. doi: 10.1007/s00415-025-13201-1. J Neurol. 2025. PMID: 40560468
Rationale and design of the ESC Heart Failure III Registry - Implementation and discovery.
Lund LH, Crespo-Leiro MG, Laroche C, Garcia-Pinilla JM, Bennis A, Vataman EB, Polovina M, Radovanovic S, Apostolovic SR, Ašanin M, Gackowski A, Kaplon-Cieslicka A, Cabac-Pogorevici I, Anker SD, Chioncel O, Coats AJS, Filippatos G, Lainscak M, Mcdonagh T, Mebazaa A, Metra M, Piepoli M, Rosano GM, Ruschitzka F, Savarese G, Seferović PM, Iung B, Popescu BA, Maggioni AP; ESC EORP HF III National Leaders and Investigators. Lund LH, et al. Eur J Heart Fail. 2023 Dec;25(12):2316-2330. doi: 10.1002/ejhf.3087. Epub 2023 Nov 29. Eur J Heart Fail. 2023. PMID: 37990135 Free article.
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.
Jain T, Estrada-Merly N, Salas MQ, Kim S, DeVos J, Chen M, Fang X, Kumar R, Andrade-Campos M, Elmariah H, Agrawal V, Aljurf M, Bacher U, Badar T, Badawy SM, Ballen K, Beitinjaneh A, Bhatt VR, Bredeson C, DeFilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi AP, Ganguly S, Gergis U, Grunwald MR, Hamad N, Hamilton BK, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-Dabaja MA, Krem MM, Lad DP, Liesveld J, Al Malki MM, Malone AK, Murthy HS, Ortí G, Patel SS, Pawarode A, Perales MA, van der Poel M, Ringden O, Rizzieri DA, Rovó A, Savani BN, Savoie ML, Seo S, Solh M, Ustun C, Verdonck LF, Wingard JR, Wirk B, Bejanyan N, Jones RJ, Nishihori T, Oran B, Nakamura R, Scott B, Saber W, Gupta V. Jain T, et al. Blood Adv. 2024 Aug 27;8(16):4281-4293. doi: 10.1182/bloodadvances.2024013451. Blood Adv. 2024. PMID: 38916866 Free PMC article.
Designed 2D/2D F-doped TiO(2)@ZnIn(2)S(4) heterojunction for efficient photo-utilization hydrogen generation.
Farhan S, Raza AH, Li L, Yang S, Wu Y. Farhan S, et al. J Colloid Interface Sci. 2025 Mar;681:1-15. doi: 10.1016/j.jcis.2024.11.124. Epub 2024 Nov 19. J Colloid Interface Sci. 2025. PMID: 39581073
The optimum hydrogen evolution rate (HER) of 1.58 mmol g(-1)h(-1) was acquired for 30-F(3)T@ZIS, which was about 15 and 2 times superior to the pristine F-doped TiO(2) and ZnIn(2)S(4), respectively. The interaction between F-doped TiO(2) and ZnIn(2)S(4) fac …
The optimum hydrogen evolution rate (HER) of 1.58 mmol g(-1)h(-1) was acquired for 30-F(3)T@ZIS, which was about 15 and 2 times sup …
The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.
Reiterer V, Figueras-Puig C, Le Guerroue F, Confalonieri S, Vecchi M, Jalapothu D, Kanse SM, Deshaies RJ, Di Fiore PP, Behrends C, Farhan H. Reiterer V, et al. EMBO J. 2017 Feb 1;36(3):260-273. doi: 10.15252/embj.201694795. Epub 2016 Dec 22. EMBO J. 2017. PMID: 28007894 Free PMC article.
The F-box protein FBXW7 is the substrate-recruiting subunit of an SCF ubiquitin ligase and a major tumor-suppressor protein that is altered in several human malignancies. ...In the current work, we have mapped the interactome of the enigmatic pseudophosphatase STYX We reas …
The F-box protein FBXW7 is the substrate-recruiting subunit of an SCF ubiquitin ligase and a major tumor-suppressor protein that is a …
Rotational Atherectomy With or Without Intravascular Lithotripsy for Patients With Heavy Coronary Artery Calcification.
Leone PP, Sartori S, Farhan S, Gitto M, Bay B, Smith K, Camaj A, Yasumura K, Oliva A, Di Muro FM, Vogel B, Vinayak M, Dhulipala V, Hasan CM, Bhatt DL, Dangas G, Mehran R, Kini A, Sharma SK. Leone PP, et al. Am J Cardiol. 2025 Jul 15;255:41-48. doi: 10.1016/j.amjcard.2025.07.002. Online ahead of print. Am J Cardiol. 2025. PMID: 40675465
Primary outcomes were incidence of final serious angiographic complications (a composite of National Heart, Lung and Blood Institute type C-F dissection, cardiac tamponade, abrupt vessel closure and slow/no flow), and of 30-day major adverse cardiovascular events (MACE), a …
Primary outcomes were incidence of final serious angiographic complications (a composite of National Heart, Lung and Blood Institute type C- …
A Systematic Review on the Clinical Pharmacokinetics of Cephalexin in Healthy and Diseased Populations.
Kanan M, Atif S, Mohammed F, Balahmar Y, Adawi Y, AlSaleem R, Farhan A, Alghoribi M, Mohammed S, Alshanbari R, Fahad M, Kallab R, Mohammed R, Alassaf D, Hazza A. Kanan M, et al. Antibiotics (Basel). 2023 Sep 3;12(9):1402. doi: 10.3390/antibiotics12091402. Antibiotics (Basel). 2023. PMID: 37760698 Free PMC article. Review.
These studies were included only based on the presence of plasma concentration-time profiles or PK parameters, i.e., maximum plasma concentration (C(max)), half-life (t(1/2)) area under the curve from time 0-infinity (AUC(0- ),) and clearance (CL/F). A dose-proportional in …
These studies were included only based on the presence of plasma concentration-time profiles or PK parameters, i.e., maximum plasma concentr …
42 results